Additionally, GSK3β, a key regulator in AD pathology, is hyperactivated, contributing to amyloid accumulation, tau hyperphosphorylation, neuroinflammation, and synaptic dysfunction, including impaired LTP [62]. This evidence concerns the gene MAPT and Alzheimer disease.